Default company panoramic image
C4f217cf 98cc 4b1d a34a 15551bd2c2f1

Spordiff Therapeutics

Unique small molecule inhibiting C diff germination, preventing most common hospital acquired infection, a $4B annual problem

  • Stage Product In Development
  • Industry Biotechnology
  • Location Belmont, MA, USA
  • Currency USD
  • Employees 0
  • Website

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.